Fig. 4From: An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapyTreatment outcome of one patient in esophagus-sparing group. Before SIB-IMRT and chemotherapy, a tumor located in right hilum was revealed on, CT (a), T2WI (b) and DWI (c). Two months after SIB-IMRT and chemotherapy, no visible tumor was observed on CT (d), T2WI (e) and DWI (f). Fifteen months after SIB-IMRT the tumor was well controlled (g, h, i)Back to article page